TAF II p100 Antibodies

Santa Cruz Biotechnology delivers a wide array of TAF II p100 monoclonal antibodies for research focused on understanding transcriptional regulation. TAF II p100 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAF II p100 functions as a key component of the transcriptional machinery, playing a significant role in the assembly of the transcription factor IID (TFIID) complex. TAF II p100 actively participates in the regulation of gene expression, influencing cellular processes such as differentiation and proliferation. Research involving TAF II p100 has revealed its importance in understanding the mechanisms underlying various diseases, including cancer. Investigating TAF II p100 can provide valuable information about transcriptional regulation and its impact on cellular function. Studying TAF II p100 helps researchers explore the complexities of gene expression control and its relationship to disease development. TAF II p100 research continues to uncover new aspects of transcriptional regulation and cellular signaling pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of transcriptional regulation and its role in health and disease.